- Home
- CCCC vs SRG Comparison
CCCC vs SRG Comparison
Compare CCCC & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- SRG
- Stock Information
- Founded
- CCCC 2015
- SRG 2014
- Country
- CCCC United States
- SRG United States
- Employees
- CCCC N/A
- SRG N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- SRG Real Estate Investment Trusts
- Sector
- CCCC Health Care
- SRG Real Estate
- Exchange
- CCCC Nasdaq
- SRG Nasdaq
- Market Cap
- CCCC 175.1M
- SRG 206.7M
- IPO Year
- CCCC 2020
- SRG 2015
- Fundamental
- Price
- CCCC $2.71
- SRG $4.36
- Analyst Decision
- CCCC Buy
- SRG
- Analyst Count
- CCCC 3
- SRG 0
- Target Price
- CCCC $8.00
- SRG N/A
- AVG Volume (30 Days)
- CCCC 1.2M
- SRG 129.3K
- Earning Date
- CCCC 10-30-2025
- SRG 08-14-2025
- Dividend Yield
- CCCC N/A
- SRG N/A
- EPS Growth
- CCCC N/A
- SRG N/A
- EPS
- CCCC N/A
- SRG N/A
- Revenue
- CCCC $34,240,000.00
- SRG $15,346,000.00
- Revenue This Year
- CCCC N/A
- SRG N/A
- Revenue Next Year
- CCCC N/A
- SRG N/A
- P/E Ratio
- CCCC N/A
- SRG N/A
- Revenue Growth
- CCCC 16.55
- SRG N/A
- 52 Week Low
- CCCC $1.09
- SRG $2.43
- 52 Week High
- CCCC $7.22
- SRG $4.77
- Technical
- Relative Strength Index (RSI)
- CCCC 60.68
- SRG 80.95
- Support Level
- CCCC $2.57
- SRG $3.61
- Resistance Level
- CCCC $2.85
- SRG $3.74
- Average True Range (ATR)
- CCCC 0.19
- SRG 0.14
- MACD
- CCCC -0.01
- SRG 0.06
- Stochastic Oscillator
- CCCC 72.88
- SRG 95.43
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.